Yasunori Sato

Kanazawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 683 publications

Study of weight loss intervention to find an effective strategy for obesity management and the TARGET of weight loss amount for reducing health disorders (SLIM-TARGET): a randomized controlled trial.

Study of weight loss intervention to find an effective strategy for obesity management and the TARGET of weight loss amount for reducing health disorders (SLIM-TARGET): a randomized controlled trial.

Journal: Endocrine journal

Published: September 02, 2026

Immune Microenvironmental Analysis of Intraductal Papillary Neoplasms of the Bile Duct in Occupational Cholangiocarcinoma: Associations with Tumor Size.

Immune Microenvironmental Analysis of Intraductal Papillary Neoplasms of the Bile Duct in Occupational Cholangiocarcinoma: Associations with Tumor Size.

Journal: Cancers

Published: July 21, 2026

Clinical Outcomes of Underwater Endoscopic Submucosal Dissection for Duodenal Tumors: A Systematic Review and Meta-Analysis.

Clinical Outcomes of Underwater Endoscopic Submucosal Dissection for Duodenal Tumors: A Systematic Review and Meta-Analysis.

Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

Published: July 13, 2026

Gingival Fibroblast-Driven Osteoimmunology via the IL-33-ILC2-IL-13 Axis.

Gingival Fibroblast-Driven Osteoimmunology via the IL-33-ILC2-IL-13 Axis.

Journal: Journal of dental research

Published: June 22, 2026

Sex modifies the association between bystander CPR and 30-day survival after out-of-hospital cardiac arrest: SOS-KANTO 2017 study.

Sex modifies the association between bystander CPR and 30-day survival after out-of-hospital cardiac arrest: SOS-KANTO 2017 study.

Journal: The American journal of emergency medicine

Published: June 13, 2026

Clinicopathological significance of methylthioadenosine phosphorylase (MTAP) expression loss in hepatobiliary tumors.

Clinicopathological significance of methylthioadenosine phosphorylase (MTAP) expression loss in hepatobiliary tumors.

Journal: Human pathology

Published: April 20, 2026

Validation of Geant4 fragmentation models for broad beam heavy-ion therapy.

Validation of Geant4 fragmentation models for broad beam heavy-ion therapy.

Journal: Physics in medicine and biology

Published: April 09, 2026

Indoleamine 2,3-Dioxygenase 1 as an Adjunctive Histopathological Marker of Cholangitis Activity in Primary Biliary Cholangitis.

Indoleamine 2,3-Dioxygenase 1 as an Adjunctive Histopathological Marker of Cholangitis Activity in Primary Biliary Cholangitis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 06, 2026

Spectrum of Biliary and Nonbiliary Neoplasms Growing and Spreading Within the Lumen of the Bile Ducts.

Spectrum of Biliary and Nonbiliary Neoplasms Growing and Spreading Within the Lumen of the Bile Ducts.

Journal: Cancers

Published: March 16, 2026

Elevated Intraocular Pressure Independently Predicts Long-Term Progression to Advanced Chronic Kidney Disease: A 20-Year Longitudinal Cohort Study.

Elevated Intraocular Pressure Independently Predicts Long-Term Progression to Advanced Chronic Kidney Disease: A 20-Year Longitudinal Cohort Study.

Journal: Nephron

Published: March 07, 2026

WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD).

WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD).

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Journal: BMC cancer

Published: January 27, 2026

Showing 1-12 of 683

Last Updated: 09/26/2026